Craft

Advanced
IMV

IMV

Total Funding

$4.2 M

IMV Summary

Company Summary

Overview
IMV is a clinical-stage immuno-oncology company. It is engaged in innovate therapies development to treat cancer and other diseases. The Company also provides a platform that helps to develop immunotherapeutics agents. 
Type
Private
Status
Active
Founded
2000
HQ
Dartmouth, CA | view all locations
Website
https://imv-inc.com
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Table of Contents

Key People

  • Frederic Ors

    Frederic Ors, CEO, Director

    • Pierre Labbé

      Pierre Labbé, Chief Financial Officer

      • Marie-Eve Charrois

        Marie-Eve Charrois, Vice President, Regulatory Affairs

        • Joseph Sullivan

          Joseph Sullivan, Senior Vice President, Business Development

          LocationsView all

          2 locations detected

          • Dartmouth, NS HQ

            Canada

            130 Eileen Stubbs Avenue, Suite 19

          • Québec, QC

            Canada

            2875 Boulevard Laurier, Delta 1, Suite 220

          IMV Financials

          Summary Financials

          Net income (FY, 2022)
          ($38.0M)
          Cash (FY, 2022)
          $21.2M
          EBIT (FY, 2022)
          ($38.1M)

          Competitors and Similar Companies

          Compare competitors

          Footer menu

          Product

          Solutions

          Resources

          Company

          © Craft.co 2026
          Share price data provided by IEX